Biomed Group
Long/short equity, healthcare, biotech

Chimerix: A Significant Player In The Antiviral Therapeutics Market

Viral diseases continue to pose some of the greatest challenges to modern medicine and therefore antiviral therapies are becoming an important, emerging area of pharmaceutical research. For many viral diseases, prophylactic vaccines are unlikely to be developed in the near future. Fortunately, effective antiviral therapies have been developed for many of these viruses. In this article, we decided to evaluate Chimerix, Inc. (NASDAQ:CMRX), a small-cap biopharmaceutical company engaged in the discovery, development, and commercialization of oral antiviral therapeutics for various medical needs.

Company Overview

Chimerix is based in Durham, North Carolina, and was founded in 1996. The company licensed lipid-conjugation technology from the University of California that has been shown to improve the potency of antivirals, and...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details